Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ratika Krishnamurty"'
Autor:
Eric T. Larson, Pratistha Ranjitkar, Stephen E. Leonard, Ethan A. Merritt, Dustin J. Maly, Ratika Krishnamurty, Edward J. Dale, Jennifer L. Brigham
Publikováno v:
Nature chemical biology
Protein kinases, key regulators of intracellular signal transduction, have emerged as an important class of drug targets. Chemical proteomic tools that facilitate the functional interrogation of protein kinase active sites are powerful reagents for s
Autor:
Pratistha, Ranjitkar, B Gayani K, Perera, Danielle L, Swaney, Daniel L, Swaney, Sanjay B, Hari, Eric T, Larson, Ratika, Krishnamurty, Ethan A, Merritt, Judit, Villén, Dustin J, Maly
Publikováno v:
Journal of the American Chemical Society. 134:19017-19025
Protein kinases are key components of most mammalian signal transduction networks and are therapeutically relevant drug targets. Efforts to study protein kinase function would benefit from new technologies that are able to profile kinases in complex
Autor:
Dustin J. Maly, Ratika Krishnamurty, Gabriel J. Brighty, Ames C. Register, Stephen E. Leonard
Publikováno v:
ACS Chemical Biology
Multidomain protein kinases, central controllers of signal transduction, use regulatory domains to modulate catalytic activity in a complex cellular environment. Additionally, these domains regulate noncatalytic functions, including cellular localiza
Publikováno v:
Bioorganicmedicinal chemistry letters. 21(1)
Affinity reagents that target protein kinases are powerful tools for signal transduction research. Here, we describe a general set of kinase ligands based on a 5-aminoindazole scaffold. This scaffold can readily be derivatized with diverse binding el
Autor:
Dustin J. Maly, Ratika Krishnamurty
Publikováno v:
ACS chemical biology. 5(1)
Protein kinases have emerged as one of the most frequently targeted families of proteins in drug discovery. While the development of small-molecule inhibitors that have the potency and selectivity necessary to be effective cancer drugs is still a for
Autor:
Dustin J. Maly, Ratika Krishnamurty
Publikováno v:
Combinatorial chemistryhigh throughput screening. 10(8)
The clinical success of the Bcr-Abl tyrosine kinase inhibitor Gleevec((R)) and the recent clinical approval of a number of small molecule drugs that target protein kinases have intensified the search for novel protein kinase inhibitors. Since most sm
Autor:
Danielle L. Swaney, Pratistha Ranjitkar, Judit Villén, Eric T. Larson, Sanjay B. Hari, B. Gayani K. Perera, Dustin J. Maly, Ethan A. Merritt, Ratika Krishnamurty
Publikováno v:
Journal of the American Chemical Society. 135:948-948